ABVX
Abivax SA American Depositary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
Abivax SA (ABVX) Stock: Buy, Sell, or Hold?
$87.58
-2.62 (-2.90%)
▼
5d:
+2.16%
30d:
-5.2%
90d:
-27.46%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (67%)
Quality Score
56/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$86.29 – $90.86
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-22.8x
Next 12M consensus est.
Wall Street Target
$163.58
+86.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$83.55 / $92.95
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: ABVX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When ABVX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ABVX is currently trading at $87.58, which is considered slightly high relative to its 30-day fair value range of $86.29 to $90.86.
Technical Outlook: Technically, ABVX is in a strong uptrend. Immediate support is located at $83.55, while resistance sits at $92.95.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $163.58 (+86.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ABVX is in a strong uptrend. Immediate support is located at $83.55, while resistance sits at $92.95.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $163.58 (+86.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$86.29 -
$90.86
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
Trading Range & Key Levels
30-Day Trading Range
$86.29 -
$90.86
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$83.55
Resistance Level
$92.95
Current Trend
Strong Uptrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 86.8% below Wall St target ($163.58)
- NEUTRAL: Bottoming setup forming (47/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-22.84
Wall Street Target
$163.58
(+86.8%)
Revenue Growth (YoY)
-6.8%
Share ABVX Analysis
Share this live ABVX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ABVX)
Bearish
1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Jul 23, 2026
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on ABVX are bearish (sentiment score +0.00) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 6:23 AM ET
Data refreshes hourly during market hours. Next update: 7:23 AM
Data refreshes hourly during market hours. Next update: 7:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABVX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 69 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 48 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 47 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ABVX Research Pages
